Mini Competition for the Supply of Human Seasonal Influenza Vaccines

<div class="h1">Titel</div> <div class="pre">Mini Competition for the Supply of Human Seasonal Influenza Vaccines</div> <div class="h1">Beschreibung</div> <div class="pre">Following publication and award to the Dynamic Purchasing System (DPS) Invitation for the supply of Various Vaccine Products (HSE 20110), the Health Service Executive (HSE) invites DPS tender submissions for the Supply of Human Seasonal Influenza Vaccines Tenderers are required to submit a Tender for the supply of up to 1.25 million doses of Human Seasonal influenza vaccine (the “Tendered Vaccines”) for the 2024/2025 season (the “Tender Process”). The requirement for Human Seasonal influenza vaccine can include Adjuvanted, Cell Based, Egg Based, High Dose and Recombinant Vaccines. The HSE reserves the right to award a portion of the total tendered dose amount to cohort specific vaccines.</div> <div class="h1">Interne Kennung</div> <div class="pre">0</div>